Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry

Journal of Immunological Methods
Karina Godoy-RamirezHans Gaines

Abstract

The assessment of cytokine production is an important component of studies of cell-mediated immune responses (CMI) to immunological challenges. In this study, we present a method to enhance the detection of cytokine-producing cells by allowing antigen-specific cells to expand in long-term culture. We investigated the influence of the degree of dilution of whole blood and the duration of the incubation period on whole blood as well as peripheral blood mononuclear cells (PBMCs), cultured in the absence or presence of mitogens, superantigens or specific antigens, for intracellular cytokine production (IFNgamma, TNFalpha, IL-2, IL-4, IL-10 and IL-13) by CD4+ and CD8+ T lymphocytes using four-colour flow cytometry. Whole blood was diluted 1/1, 1/2, 1/5 and 1/10, and cultured for 6, 24, 48, 72 and 120 h in the presence of antibodies against the co-stimulatory molecules CD28 and CD49d, and, during the last 4 h of culture, in the presence of brefeldin A. Optimum conditions for detection of a high number of IFNgamma-positive cells were observed after 72 h of culture in blood diluted 1/10. Median frequencies of IFNgamma+ cells obtained after activation by PMA-ionomycin, PHA or SEA-B were 29.3%, 20.0% and 6.8% for CD4+ cells, and 67.8%, 2...Continue Reading

References

Jan 1, 1990·Annual Review of Biochemistry·K I AraiT Yokota
Dec 1, 1985·Journal of Virological Methods·P LjungmanV A Sundqvist
May 23, 1985·Journal of Immunological Methods·M LerouxH Kirchner
Aug 1, 1995·The Journal of Experimental Medicine·F D Finkelman
Sep 25, 1995·Journal of Immunological Methods·S HoefakkerE Claassen
May 1, 1993·Immunology Today·L M BradleyS L Swain
Apr 1, 1997·Current Opinion in Immunology·L L Carter, S L Swain
Jul 22, 1998·Journal of Immunological Methods·M A SuniV C Maino
Feb 26, 1999·Journal of Immunological Methods·B MascherM Seyfarth
Apr 7, 1999·The Journal of Infectious Diseases·E G KallasT G Evans
Sep 15, 2000·Journal of Immunological Methods·P PalaP J Openshaw
Jun 29, 2002·The Journal of Infectious Diseases·Holli S DunnHolden T Maecker
Aug 15, 2002·Transactions of the Royal Society of Tropical Medicine and Hygiene·Martha Cecilia Moreno-LafontLeopoldo Santos-Argumedo
Nov 18, 2003·Immunological Reviews·Maria P Hernandez-FuentesRobert I Lechler

❮ Previous
Next ❯

Citations

Mar 12, 2013·European Journal of Pharmacology·Tabasum SidiqRakesh Kamal Johri
Jan 27, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mareen MatzKlemens Budde
Apr 15, 2009·Biochemistry. Biokhimii︠a︡·I S LitvinovM P Kirpichnikov
Feb 7, 2009·Journal of Leukocyte Biology·Gregory B PottLeland Shapiro
Aug 5, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·O MillánM Brunet
Sep 9, 2015·Biotechnology and Bioengineering·Lina SchukurMartin Fussenegger
Jan 16, 2013·Journal of Immunological Methods·Kimberly A LivingstonCharles B Stephensen
Sep 9, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Olga MillánMercè Brunet
Mar 30, 2005·Clinical Lymphoma·Kartik KonduriMarvin J Stone
Jul 13, 2007·Toxicology Letters·Paurene DuramadNina T Holland
May 19, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Edward A HirschowitzJohn R Yannelli
Sep 13, 2008·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Sarah MeierAndreas Thiel
Aug 14, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·O Rodríguez-FandiñoM Schmulson
Apr 14, 2016·Journal of Immunological Methods·Sofie Bruun HartmannGregers Jungersen
Jun 2, 2015·American Journal of Respiratory and Critical Care Medicine·Patricio EscalanteAndrew H Limper
May 7, 2014·Journal of Virological Methods·Louise A CarolanKaren L Laurie
Jun 28, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Megan L KrauseSherine E Gabriel
Jan 8, 2011·Vaccine·Kristin ScheibleDavid J Topham
Jul 21, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Ulrike BühlerFrauke Zipp
Jan 4, 2017·Journal of Neurogastroenterology and Motility·Oscar A Rodríguez-FandiñoMax J Schmulson
May 19, 2010·Expert Review of Clinical Immunology·Peter J BugelskiEsther Bouman-Thio
May 28, 2019·Parasite Immunology·Umut GaziAysegul Taylan-Ozkan
Aug 2, 2020·British Journal of Pharmacology·Pedro F PinheiroM Matilde Marques
May 25, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·John M DavisSherine E Gabriel
Nov 21, 2020·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Neha ChaudharyClaire Wynne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.